Here is a short summary of my interpretation of all the TV
Here is a short summary of my interpretation of all the TV clips by reporters:
- Drug works as advertised, i.e. rapidly reduces inflammation in the lungs of ARDS affected patients
- This is a game changer as it can be the difference between life and death
- It appears that 10 out of 10 patients who were administered Leronlimab in the ICU responded positively
- Unclear as to how many of these 10 patients in the ICU were on respirators? We know at least 2 were extubated for sure. Could be more if they were on respirators but unclear ...
- The reporter, not NP, said all 10 patients were out of the ICU. Seems fast but I guess if they recovered enough other patients maybe worse off?
Now, some other thoughts:
- Based on everything I have read, there is still no “new” proven safe therapeutic drug. Many being developed but at least 12-18 months before commercial use
- Vaccines are in the same boat, 12-18 months
- Of the existing drugs that maybe partially effective and have proven safety records, NONE have the type of MOA that can save a patient in ARDS mode aside from Leronlimab (this claim is to be finalized in the next 3-4 weeks with FDA approved controlled tests).
- Testing now extended to early and moderate corona virus cases. Again results in 3-4 weeks. High likelihood of the same MOA will result in positive outcomes.
- These short time frames to potential commercial success and revenues are unheard of!
Lastly,
- This MOA has now validated Leronlimab’s potential for so many immunological related illnesses that NP has alluded to but no time or money to test
- And as others have documented, the enormous progress Cytodyn has had in HIV, cancer, etc... will now get so much more visibility in both the medical world and in the eyes of the general public!
Only good days ahead!!!
8
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...
Continue Reading
Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...
Continue Reading
Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...
Continue Reading
Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....
Continue Reading
Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...
Continue Reading
Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...
Continue Reading
Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...
Continue Reading
CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...
Continue Reading
A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...
Continue Reading
Breaking New Ground in Golf and Luxury Cabot and the Bragg family are cooking up something extraordinary in Cumberland County, Nova Scotia. The new luxury lifestyle and golf destination, Cabot Wilds, promises to be more than just a retreat—it's a bold statement on how to marry nature, luxury, and community. Set to open in late 2027, this expansive 2,500-acre resort will...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding ASML Holding's Recent Options Activity Investors have recently taken a noticeably bearish stance towards ASML Holding (NASDAQ: ASML), a situation that all market participants should take note of. Observations from public options records suggest that this attitude merits close examination. While the identities of these investors remain a mystery, significant...
Continue Reading
Coloplast A/S: An Overview of Share Trading Activities Coloplast A/S is a renowned global company specializing in medical devices and services, primarily focusing on ostomy care, continence care, urology, and wound care. As a publicly traded company, Coloplast's shares are actively traded on the Copenhagen Stock Exchange under the ticker Copenhagen:COLO B. In this...
Continue Reading
Galan Lithium Limited Secures Funding for Growth Galan Lithium Limited (NASDAQ: GLN) has successfully navigated the conditions necessary to proceed with a notable $20 million placement to the Clean Elements Fund. This funding is crucial for advancing the compelling Hombre Muerto West (HMW) lithium project, which is being recognized for its significant scale and high-grade...
Continue Reading
Biocon Biologics to Showcase Innovations at Key Conference Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), is preparing to present at a major annual healthcare conference, scheduled for mid-January. The conference will provide a platform for Biocon Biologics to highlight their...
Continue Reading
Innovative Growth for BrainsWay in Q2 2025 BrainsWay Ltd. (NASDAQ: BWAY), a pioneering company in neurostimulation treatments, recently showcased remarkable performance for the second quarter of 2025. The company reported a record revenue of $12.6 million, marking a substantial 26% increase compared to the same period last year. Financial Highlights During Q2 2025,...
Continue Reading